Drug Profile
Alitretinoin oral - Stiefel Laboratories
Alternative Names: Alitoc; Alitretinoin - Basilea; BAL-4979; BAL4079; Cehado; Once-daily oral alitretinoin - Basilea; ToctinoLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Basilea Pharmaceutica
- Developer Basilea Pharmaceutica; Stiefel Laboratories
- Class Antineoplastics; Keratolytics; Retinoids; Skin disorder therapies; Small molecules
- Mechanism of Action Retinoic acid receptor agonists; Retinoid X receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Eczema
- Phase III Skin disorders
- Discontinued Palmoplantar pustulosis; Systemic lupus erythematosus